Minister of State for Chemicals and Fertilizers Mansukh Mandaviya has said, National Pharmaceuticals Pricing Authority (NPPA) has directed hospitals to issue detailed bills to the patients and separately mention the cost of the Coronary Stents, along with the brand name of the manufacturer and importer.<br/><br/>In a written reply to a question in Lok Sabha today, Mr Mandaviya said, non-compliance of the order will be treated as deliberate distortion of evidence along with charges of overpricing inviting prosecution under the Essential Commodities Act. <br/><br/>The Minister said, the NPPA is closely monitoring the situation and has alerted the State governments and State Drugs Controllers to monitor the availability of stents. He said, industry has also been apprised that all manufactures and importers are under legal obligation to maintain smooth production and supply of coronary stents of all brands which were available in the country before price cap. <br/><br/>Mr Mandaviya informed that aggrieved persons may send verifiable information and complaints regarding this on NPPA Help Line Number–1800111255 or through online complaint mechanism Pharma Jan Samadhan.<br/><br/>